Skip to main content
. 2021 Jul 31;23(9):966–978. doi: 10.1016/j.neo.2021.07.010

Fig. 1.

Fig. 1

High levels of Hpa2 are associated with longer survival of gastric cancer patients. (A) Immunostaining. Tumor biopsies and adjacent normal gastric tissues were subjected to immunostaining applying anti-Hpa2 antibody. Shown are representative images of Hpa2 staining in normal gastric tissue (left) and gastric carcinoma stained negative (middle) and positive (right) for Hpa2. Original magnifications: x10 (upper panels), x100 (lower panels). (B) Kaplan-Meier survival plot. Kaplan-Meier survival analysis of gastric cancer patients according to their Hpa2 staining intensities (high vs low). Gastric carcinoma patients exhibiting strong staining of Hpa2 (n = 56) survive significantly longer than patients that show low levels of Hpa2 (n = 79; P= 0.004). Hpa2, heparanase 2.